Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoNT-A for Postural Control in Hemiplegic CP
NCT04940143Unknown
- Sponsor
- Marmara University
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Marmara University. Primary endpoints: Modified Clinical Test of Sensory Interaction on Balance at 3 months and Light touch pressure threshold at 3 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT04940143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940143.